We therefore predict that each of the CCR2 and CCR5 receptors has a complementary role in infection-associated inflammation and tissue sequelae in COVID-19 with CCR2/CCL2 seen in both early and late stages of infection and CCR5/CCL5 seen later in the infectious process [63]. This evidence concerns the gene CCL5 and infection.